Which NOAC scores highest for AF?
New ranking may help guide doctors
4th December 2017
Apixaban is the most efficient non-vitamin K oral anticoagulant (NOAC) for treating atrial fibrillation, according to the results of a meta-analysis including 95,000 patients from 23 randomised controlled trial.

There's already a large body of evidence that NOACs are at least as effective as warfarin and safer to use.
But while the authors of the latest review note that all NOACs have a lower risk of all-cause mortality compared with warfarin, some have more favourable profiles.
They conclude that apixaban is the best treatment option for most outcomes and